BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17961559)

  • 1. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation.
    Lofrano-Porto A; Casulari LA; Nascimento PP; Giacomini L; Naves LA; da Motta LD; Layman LC
    Fertil Steril; 2008 Oct; 90(4):1169-74. PubMed ID: 17961559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes.
    Berger K; Souza H; Brito VN; d'Alva CB; Mendonca BB; Latronico AC
    Fertil Steril; 2005 Feb; 83(2):466-70. PubMed ID: 15705395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent primary follicle-stimulating hormone deficiency is a rare cause of treatable male infertility.
    Giltay JC; Deege M; Blankenstein RA; Kastrop PM; Wijmenga C; Lock TT
    Fertil Steril; 2004 Mar; 81(3):693-6. PubMed ID: 15037424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipoprotein, equine luteinizing hormone, equine follicle-stimulating hormone, and equine prolactin on equine testicular steroidogenesis in vitro.
    Eisenhauer KM; Roser JF
    J Androl; 1995; 16(1):18-27. PubMed ID: 7768749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated follicle-stimulating hormone (FSH) deficiency without mutation of the FSHbeta gene and successful treatment with human menopausal gonadotropin.
    Murao K; Imachi H; Muraoka T; Fujiwara M; Kushida Y; Haba R; Ishida T
    Fertil Steril; 2008 Nov; 90(5):2012.e17-9. PubMed ID: 18402948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
    Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
    Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT; Kulin HE; Garibaldi L; Suriano MJ; Bracki K; Pang S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones.
    de Bruin D; de Jong IJ; Arts EG; Nuver J; Dullaart RP; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    Fertil Steril; 2009 Jun; 91(6):2481-6. PubMed ID: 18440530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
    Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
    Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
    de Koning CH; Schoemaker J; Lambalk CB
    Fertil Steril; 2004 Sep; 82(3):650-3. PubMed ID: 15374709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and endocrinological analysis of combined buserelin-pure FSH-hCG therapy in patients with polycystic ovary syndrome].
    Ohkura T; Watabe H; Horinaka T; Segawa Y; Hayashi M; Yaoi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Oct; 46(10):1013-9. PubMed ID: 7814930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
    Mannaerts B; Fauser B; Lahlou N; Harlin J; Shoham Z; Bennink HC; Bouchard P
    Fertil Steril; 1996 Feb; 65(2):406-10. PubMed ID: 8566271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of a novel follicle-stimulating hormone/human chorionic gonadotropin chimeric gonadotropin.
    Garone LM; Ammannati E; Brush TS; Fischer DJ; Tos EG; Luo J; Altobello KL; Ciampolillo C; Ihley TM; Kurosawa E; Tiebout A; McKenna S
    Endocrinology; 2006 Sep; 147(9):4205-12. PubMed ID: 16794004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tilapia follicle-stimulating hormone (FSH): immunochemistry, stimulation by gonadotropin-releasing hormone, and effect of biologically active recombinant FSH on steroid secretion.
    Aizen J; Kasuto H; Golan M; Zakay H; Levavi-Sivan B
    Biol Reprod; 2007 Apr; 76(4):692-700. PubMed ID: 17192515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor.
    Vaskivuo TE; Aittomäki K; Anttonen M; Ruokonen A; Herva R; Osawa Y; Heikinheimo M; Huhtaniemi I; Tapanainen JS
    Fertil Steril; 2002 Jul; 78(1):108-13. PubMed ID: 12095499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
    Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.